Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gushengtang HoldingsFRA:F2P -0.68%88 EV-to-EBITDA is 7.68 as of Aug. 20, 2026, which is 43% below its 10-year median of 13.46. GuruFocus rates FRA:F2P with a GF Score™ of 88/100 and a GF Value™ of €6.40. The stock has 4 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Gushengtang Holdings ranks better than 68.42% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Gushengtang Holdings's enterprise value is €593.0 Mil.
Gushengtang Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €77.2 Mil. Therefore, Gushengtang Holdings's EV-to-EBITDA for today is 7.68.
The historical rank and industry rank for Gushengtang Holdings's EV-to-EBITDA or its related term are showing as below:
FRA:F2P'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -43.46 Med: 13.46 Max: 36.49
Current: 7.68
During the past 8 years, the highest EV-to-EBITDA of Gushengtang Holdings was 36.49. The lowest was -43.46. And the median was 13.46.
FRA:F2P's EV-to-EBITDA is ranked better than 68.42% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs FRA:F2P: 7.68
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gushengtang Holdings's PE Ratio (TTM) for today is calculated as:
Gushengtang Holdings's share price for today is €2.94.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gushengtang Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.176.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Gushengtang Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Gushengtang Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gushengtang Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gushengtang Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Gushengtang Holdings's EV-to-EBITDA falls into.
Gushengtang Holdings's current Enterprise Value is €593.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gushengtang Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €77.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gushengtang Holdings (FRA:F2P) has a EV-to-EBITDA of 7.68 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Gushengtang Holdings. This is 43% below median its historical median of 13.46. According to the industry distribution chart, Gushengtang Holdings ranks #162 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 31.6%.
Is Gushengtang Holdings' EV-to-EBITDA too high?
Gushengtang Holdings' current EV-to-EBITDA of 7.68 is 43% below median its 10-year median of 13.46. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. Gushengtang Holdings' value of 7.68 is 28.6% below this industry median. Based on the distribution chart, Gushengtang Holdings ranks #162 out of 513 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Gushengtang Holdings has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Gushengtang Holdings' EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gushengtang Holdings ranks #162 out of 513 companies for EV-to-EBITDA. This puts Gushengtang Holdings in the upper half of its industry. The industry median EV-to-EBITDA is 10.76. Gushengtang Holdings' value of 7.68 is 28.6% below this benchmark. While the company's 10-year median is 13.46 vs. the industry median of 10.76, Gushengtang Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gushengtang Holdings's current EV-to-EBITDA of 7.68 is 28.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Gushengtang Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gushengtang Holdings's current EV-to-EBITDA is 7.68, which is 43% below median its own 10-year median of 13.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gushengtang Holdings stock overvalued right now?
Gushengtang Holdings (FRA:F2P) has a current EV-to-EBITDA of 7.68. The stock's GF Value™ is €6.40, compared to a current price of €2.94 — trading 54.1% below its estimated fair value. The current EV-to-EBITDA is 7.68, which is 43% below median its 10-year median of 13.46 and 28.6% below the Healthcare Providers & Services industry median of 10.76. Gushengtang Holdings' overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Gushengtang Holdings (FRA:F2P), the current EV-to-EBITDA is 7.68 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gushengtang Holdings (FRA:F2P) Overvalued in 2026?
Based on GuruFocus' analysis, Gushengtang Holdings stock appears to be undervalued.
The current stock price of €2.94 is trading 54.1% below its estimated GF Value™ of €6.40.
Key valuation signals for FRA:F2P:
EV-to-EBITDA: 7.68 (43% below median its 10-year median of 13.46)
GF Value™: €6.40 vs. price of €2.94 (54.1% below fair value)
Industry Position: 28.6% below the Healthcare Providers & Services median (#162 of 513)
No single metric tells the full story. See the FRA:F2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gushengtang Holdings Ltd is a traditional chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. All of the group's revenue is derived from the PRC.
88GF Score
Get the complete analysis for FRA:F2P
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F2P has been successfully added to your 
